GeoVax Labs, Inc.
GeoVax Labs develops MVA-based vaccines for mpox and smallpox, with GEO-MVA entering Phase 3 in late 2026.
SCHEDULE 13GNov 16Latest SEC filing
Nov 9Latest story
November 2026
October 2026
September 2026
August 2026
July 2026
GeoVax Labs develops MVA-based vaccines for mpox and smallpox, with GEO-MVA entering Phase 3 in late 2026.
November 2026
October 2026
September 2026
August 2026
July 2026